No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects

By Yao Lei  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 237-242

Springer Publishing Company

Access to resources Recommend Favorite

Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis

By Yuan Weiguang  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 467-472

Springer Publishing Company

Access to resources Recommend Favorite

Correlation of the BACH1 Pro919Ser polymorphism with breast cancer risk: A literaturebased metaanalysis and metaregression analysis

By          

Experimental and Therapeutic Medicine, Vol. 6, Iss. 2, 2013-01 ,pp. : 435-444

Spandidos Publications

Access to resources Recommend Favorite

Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent meta-analysis

By Economopoulos Konstantinos  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 293-294

Springer Publishing Company

Access to resources Recommend Favorite

The association between TA-repeat polymorphism in the promoter region of UGT1A1 and breast cancer risk: a meta-analysis

By Yao Lei   Qiu Li-Xin   Yu Lu   Yang Zhen   Yu Xia-Jia   Zhong Yang   Yu Long  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 879-882

Springer Publishing Company

Access to resources Recommend Favorite